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AbstrACt
Objectives Our study aimed to evaluate the effectiveness 
of general practitioners’ (GPs’) smoking cessation support 
(SCS).
study design We carried out a cross-sectional study 
between February and April 2016.
setting and participant A sample of 2904 regular 
smokers aged 18 years or older was selected randomly 
from 18 general medical practices involved in a national 
representative, general medical practice-based morbidity 
monitoring system. The GPs surveyed the selected adults 
and identified 708 regular smokers.
Main outcome measures Multivariate logistic regression 
models have been applied to evaluate the determinants 
(age, gender, education, smoking-related comorbidity, 
smoking intensity, intention to quit smoking and 
nicotine dependence) of provision of GP-mediated SCS 
such as brief intervention, pharmacological and non-
pharmacological programmatic support.
results According to the survey, 24.4% of the 
adults were regular smokers, 30% of them showed 
high nicotine dependence and 38.2% willing to quit 
smoking. Most of the smokers were not participated 
in SCS by GPs: brief intervention, programmatic non-
pharmacological support and pharmacotherapy were 
provided for 25%, 7% and 2% of smokers, respectively. 
Low-nicotine-dependence individuals were less (OR 
0.30, 95% CI 0.12 to 0.75), patients with intention to 
quit were more (OR 1.49, 95% CI 1.00 to 2.22) likely to 
receive a brief intervention. Vocational (OR 1.71, 95% CI 
1.13 to 2.59) and high school education (OR 2.08, 
95% CI 1.31 to 3.31), chronic obstructive pulmonary 
disease and cardiovascular diseases (OR 3.34, 95% CI 
1.04 to 10.68; OR 3.91, 95% CI 2.33 to 6.54) increased 
the probability to receive support by GP.
Conclusions Although there are differences among 
smokers’ subgroups, the SCS in Hungarian primary 
care is generally insufficient, compared with guidelines. 
Practically, the pharmacological support is not included 
in Hungarian GPs’ practice. GPs should increase 
substantially the working time devoted to SCS, and the 
organisation of primary healthcare should support GPs in 
improving SCS services.
IntrOduCtIOn 
One of the defined elements of preventive 
health services provided in primary health-
care (PHC) is the identification of subjects 
exposed to risk factors of major chronic 
diseases. One of the most important risk 
factors to be controlled is smoking. Although 
in Hungary, the legal framework covering 
these activities has been established, smoking 
behaviour is still being assessed at a low preva-
lence by general practitioners (GPs).1 2 
Nowadays, smoking poses the greatest risk 
for healthy life years: 15.03% of healthy life 
years are lost in Hungary as a consequence 
of smoking, and hence, after Greenland 
(17.74%), Montenegro (16.02%) and North 
Korea (15.68%), Hungary has the fourth-
worst rate worldwide.3 Therefore, reducing 
smoking-related health loss constitutes a 
great public health challenge for this country. 
This unfavourable status draws attention to 
the fact that evidence-based interventions to 
control smoking have not been transposed 
effectively into everyday practice.
To facilitate smoking cessation support 
(SCS), the Ministry of Human Capacities 
released the guideline entitled, Guideline on 
Supporting Smoking Cessation—A Guide for 
strengths and limitations of this study
 ► This paper is the first Hungarian publication on the 
distribution of nicotine dependence and primary 
care smoking cessation support for adult smokers.
 ► The studied sample represents the adult smoker 
population of the country.
 ► Since our study was carried out with general 
practitioners (GPs) who volunteered to participate, 
the quality of care provided by them may be better 
than the average GP in Hungary; thus, our results 
overestimate the actual quality.
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Health Professionals, which was prepared on the basis of 
international recommendations.4–6 This guideline speci-
fies that it is the responsibility of all healthcare profes-
sionals (GPs among them) to provide SCS for tobacco 
users according to their position in the healthcare system.
Considering smoking cessation interventions, PHC 
professionals are in a key position, the help provided to 
smoking patients in general medical practice (GMP) is 
the best preventive action in terms of cost-effectiveness, 
resulting in significant health and economic benefits at 
the level of the whole society.7 Brief interventions (assess-
ment of smoking behaviour, smoking cessation advising, 
confirmation of intent to quit smoking and motivation 
thereof) and programmatic forms of support (non-phar-
macological and pharmacotherapy) can be incorporated 
into day-to-day PHC.
Each of these SCS services is among the most efficient 
smoking intervention strategies. Those smokers receiving 
such support are more likely to quit smoking.8 9 However, 
the effectiveness and applicability of support tools 
depends to a large extent on the smokers’ motivation for 
quitting smoking as well as on the level of nicotine depen-
dence. While brief intervention is a form of intervention 
applicable for all smokers, the above-mentioned two 
factors have a significant effect on the use of program-
matic support. The motivation to quit smoking is essential 
for choosing the appropriate method of non-pharma-
cological programmatic support (namely, individual 
counselling, group counselling and proactive telephone 
counselling). Furthermore, counselling is effective for 
treating both low and high forms of addiction, so their 
use should not be limited to only severe addiction cases. 
By contrast, pharmacotherapy (namely, nicotine replace-
ment therapy and varenicline) is only recommended for 
sufficiently motivated patients suffering from moderate to 
high nicotine dependence, according to the Hungarian 
guidelines.4
In Hungary, studies to specifically examine the distri-
bution of nicotine dependence as well as to monitor the 
implementation of activities provided for smokers and 
specified by guidelines have not yet been carried out. 
Therefore, our study aimed to establish a SCS-related 
data collection system and to answer the following ques-
tions: (1) What is the distribution of nicotine dependence 
among adult smokers in Hungary? (2) What types of SCS 
services do smokers receive within the framework of PHC? 
(3) What characteristics have an influence on the extent 
of nicotine dependence and on the usage of GP-based 
SCS? and (4) Another goal was to investigate the level of 
burden imposed on PHC workers by SCS services.
MethOds
The University of Debrecen, School of Public Health 
has been operating the General Practitioners’ Morbidity 
Sentinel Stations Programme (GPMSSP) since 1998, 
which includes 124 GP providing incidence and preva-
lence data on the most important non-communicable 
diseases in terms of public health.10 The collected data 
are demographically representative of the Hungarian 
adult population, providing a useful basis for carrying out 
different epidemiological studies. Based on the GPMSSP, 
we carried out a cross-sectional study in 2016 in the period 
between February and April.
sampling
The selection of adult smokers was performed by two-step 
sampling. The first step was to randomly select GMPs 
from the GPMSSP to participate in the investigation. In 
this way, 18 practices were selected. After that, patients 
aged over 18 were selected from the practice list of partic-
ipating GMPs by simple randomisation.
Taking into consideration that our aim was to investi-
gate 40 patients per practice, and the smoking frequency 
among adults is 22.5% in Hungary on the basis of the Euro-
pean Health Interview Survey, 2009 (EHIS), the number 
of selected subjects was 178 per practice. After checking 
the sampling frame, which consisted of 3204 patients, 
the GPs compiled the list of patients who received actual 
care in their practice. Thus, a total of 2904 patients were 
included in the study.
The GPs surveyed the selected adults in order to identify 
regular smokers. Pregnant women were excluded from 
the study. The data collection was carried out among of 
patients who signed the informed consent.
data collection
The data collection performed by GPs and practice nurses 
focused on demographical data (sex and age groups 
18–34, 35–64 and over 65 years), level of education 
(categorised as primary or less, vocational, high school, 
tertiary), intensity of smoking (number of cigarettes per 
day, time of smoking the first cigarette after waking up in 
the morning), intention to quit smoking (answer to ‘Do 
you want to quit smoking?’ question categorised as Yes 
or No), as well as exposure to SCS (distinguishing brief 
intervention, pharmacological support and program-
matic non-pharmacological support according to the 
Hungarian guidelines for SCS). Accompanying smok-
ing-related diseases with highest prevalence, for example, 
chronic obstructive pulmonary disease (COPD) and 
cardiovascular diseases (arterial hypertension, stroke, 
ischaemic heart disease and acute myocardial infarction) 
were also covered by data collection.
Because Heaviness of Smoking Index (HSI) has similar 
effectiveness in assessing nicotine dependence as Fager-
ström Test for Nicotine Dependence has, but HSI takes 
less resource in survey,11 12 nicotine dependence was 
calculated on the basis of the HSI from the number of 
daily cigarettes (≤10: 0 points, 11–20: 1 point, 21–30: 
2 points, ≥31: 3 points) and the time of the first ciga-
rette after waking up in the morning (≤5 min: 3 points, 
6–30 min: 2 points, 31–60 min: 1 point, >60 min: 0 points). 
Accordingly, the severity of smoking was categorised as 
low (sum of points is 0), moderate (1–3 points) or high 
(4–6 points).13 14
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statistical methods
Multivariate logistic regression models were applied to 
evaluate the influence of smokers’ characteristics on the 
level of nicotine dependence and on the provision of SCS 
by GPs. Different SCS services were examined in separate 
models. The associations were described by the OR and 
the corresponding 95% CI. The explanatory variables 
in the regression models for nicotine dependence were 
age, gender, education and accompanying diseases. In 
addition to these factors, the extent of nicotine depen-
dence and the intention to quit smoking were also taken 
into account. Predictive Analytics Software Statistics for 
Windows, V.18 (SPSS) was used for data processing and 
statistical analyses.
results
descriptive statistics
According to the GP survey, 24.4% of the adults in the 
sample smoked cigarettes regularly (95% CI 22.8% to 
25.9%). The frequency of smoking among men was 
30.6% (95% CI 28.1% to 33.1%), while it was 19.3% (95% 
CI 17.3% to 21.2%) among women. Since 651 of 708 
smokers signed the informed consent form, the response 
rate was 91.9% (figure 1).
The male to female ratio in the sample was 1.411 
(Nmale=381; Nfemale=270).Twenty-seven per cent of the 
participants were between 18 and 34 years of age, 64% 
were between 35 and 64 years of age and 9% were over 
65 years. Thirty-eight per cent of the respondents had a 
primary education, 33% of them had vocational qualifi-
cation, 22% had high school qualifications and 6% had 
tertiary education. Fifteen per cent of smokers had some 
smoking-related diseases, and the diseases with highest 
frequency were cardiovascular disease (14%) and COPD 
(2%).
Nicotine dependence was observed to be low in 8% of 
smokers, while 62% had moderate levels and 30% had high 
levels of nicotine dependence. 38.2% of the participants 
stated that they want to quit smoking, and 10%, 67% and 
23% of them had low, moderate and high dependence, 
respectively. In the years prior to the study, 25% of adults 
had participated in a brief intervention, while this rate 
was 28% among those who wanted to quit smoking—6%, 
76% and 18% for low, moderate and high dependence, 
respectively. Seven per cent of smokers received program-
matic non-pharmacological SCS, while this figure was 
only 2% regarding those who were involved in pharmaco-
therapy. Due to these low frequencies, the programmatic 
pharmacotherapy and non-pharmacological program-
matic support were aggregated into a programmatic 
support category when carrying out the regression anal-
yses. In total, 32% of the respondents received a form 
of SCS. Eight per cent of smokers interested in quitting 
tobacco received pharmacotherapy or non-pharmacolog-
ical programmatic support, while non-pharmacological 
support among smokers with high dependence was not 
achieved at all. However, 25% of the high dependence 
smokers received pharmacological support (table 1).
high-risk groups underserviced
Nicotine dependence was significantly influenced by 
gender and education level. A low dependence was less 
likely to occur among men (OR 0.39, 95% CI 0.21 to 
Figure 1 Sampling procedure.
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0.73), while the occurrence of a low dependence among 
participants with high school qualifications or tertiary 
education proved to be significantly higher (ORhigh school 
3.37, 95% CI 1.55 to 7.32; ORtertiary 6.95, 95% CI 2.65 to 
18.27). A moderate dependence was significantly higher 
among smokers with a high school education level (ORvo-
cational 1.74, 95% CI 1.19 to 2.54; ORhigh school 1.62, 95% CI 
1.05 to 2.48). A high dependence was more likely to occur 
among men (OR 1.89, 95% CI 1.31 to 2.72), and it was 
less likely to arise among smokers with a high school and 
tertiary education level (ORvocational 0.54, 95% CI 0.36 to 
0.80; ORhigh school 0.36, 95% CI 0.22 to 0.58; ORtertiary 0.27, 
95% CI 0.11 to 0.68) (table 2).
Factors affecting the provision of smoking cessation care 
are shown in table 3. A brief intervention was less likely to 
be provided to dependent patients over 35 years of age 
(OR35–64 0.46, 95% CI 0.30 to 0.70; OR65+ 0.41, 95% CI 0.19 
to 0.88) or to low dependence smokers (OR 0.30, 95% CI 
0.12 to 0.75). By contrast, dependent patients with a high 
school education level (OR 1.74, 95% CI 1.05 to 2.90), 
dependents suffering from cardiovascular diseases (OR 
6.58, 95% CI 3.80 to 11.37), dependent smokers having 
COPD (OR 4.58, 95% CI 1.36 to 15.46) and those who 
wanted to quit smoking (OR 1.49, 95% CI 1.00 to 2.22) 
were more likely to receive brief intervention. Men were 
less likely to receive programmatic support (OR 0.50, 
95% CI 0.28 to 0.91). Smokers belonging to the age group 
35–64 years of age (OR 2.12, 95% CI 1.01 to 4.46) and 
dependent patients with a high school education (ORvo-
cational 2.23, 95% CI 1.03 to 4.84; ORhigh school 3.42, 95% CI 
1.54 to 7.60) were more likely to receive programmatic 
support. Patients with a high school education (ORvo-
cational 1.71, 95% CI 1.13 to 2.59; ORhigh school 2.08, 95% CI 
1.31 to 3.31) as well as those suffering from cardiovas-
cular diseases (OR 3.91, 95% CI 2.33 to 6.54) or COPD 
(OR 3.34, 95% CI 1.04 to 10.68) had a higher chance of 
receiving a form of SCS. People with a low nicotine depen-
dence were almost significantly less likely to receive any 
kind of support (OR 0.50, 95% CI 0.24 to 1.01) (table 3).
GP’s workload for sCs
Based on the estimated frequency of smoking, and consid-
ering that the average number of adults cared for in an 
average GMP is 1613, there are 394 patients who smoke 
regularly in a typical medical practice. If the SCS of GPs 
was only focused on smokers who wanted to quit smoking 
Table 1 Distribution of nicotine dependence by gender, age, education and smoking cessation support in the years prior to 
the study according to interest in quitting
Characteristics
Whole 
sample
No interest in quitting Interest in quitting
HSI HSI
n (%)
Low
n (%)
Moderate
n (%)
High
n (%) P value*
Low
n (%)
Moderate
n (%)
High
n (%) P value*
Gender
  Female 270 (41) 19 (12) 92 (61) 41 (27) <0.001 15 (13) 84 (71) 19 (16) 0.026
  Male 381 (59) 8 (3) 144 (58) 98 (39) 10 (8) 82 (62) 39 (30)
Age group
  18–34 179 (27) 9 (9) 63 (60) 33 (31) 0.524 9 (12) 50 (68) 15 (20) 0.777
  35–64 414 (64) 17 (7) 151 (59) 88 (34) 15 (10) 103 (65) 40 (25)
  65+ 58 (9) 1 (2) 22 (54) 18 (44) 1 (6) 13 (76) 3 (18)
Education level
  Primary or less 249 (38) 4 (2) 91 (55) 72 (43) <0.001 7 (8) 45 (55) 30 (37) 0.003
  Vocational 216 (33) 5 (4) 83 (63) 44 (33) 5 (6) 62 (74%) 17 (20)
  High school 146 (22) 12 (15) 51 (64) 17 (21) 9 (13) 46 (70) 11 (17)
  Tertiary 40 (6) 6 (26) 11 (48) 6 (26) 4 (24) 13 (76) 0 (0)
Smoking cessation support
  Brief intervention 163 (25) 2 (2) 56 (61) 34 (37) 0.138 4 (6) 54 (76) 13 (18) 0.117
  Non-pharmacological 
support
45 (7) 2 (6) 21 (68) 8 (26) 0.544 4 (29) 10 (71) 0 (0) 0.014
  Pharmacotherapy 11 (2) 0 (0) 3 (100) 0 (0) 0.345 1 (12) 5 (63) 2 (25) 0.960
  Programmatic support† 54 (8) 2 (6) 23 (70) 8 (24) 0.392 5 (24) 14 (67) 2 (9) 0.045
  Any cessation support 208 (32) 4 (3%) 77 (63) 42 (34) 0.162 8 (9) 63 (74) 14 (17) 0.157
Total 651 27 (7%) 236 (59) 139 (34) 25 (10) 166 (67) 58 (23) 0.002
*χ2 test.
†Non-pharmacological programmatic support and pharmacological programmatic support have been summarised as programmatic 
support.
HSI, Heaviness of Smoking Index.
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(38.2% of the smokers according to our finding), support 
would be provided for 151 patients per practice. Consid-
ering the distribution of nicotine dependence, this figure 
would represent 15 patients with a low, 101 patients with a 
moderate and 35 patients with a high dependence.
Based on the observed care frequency, there is a lack 
of brief intervention in the case of 14 patients with a low 
dependence, 24 patients with a moderate dependence 
and 29 patients with a high dependence. Programmatic 
non-pharmacological support failed to be provided for 
11 patients with a low dependence, 29 patients with 
a moderate dependence and 35 patients with a high 
dependence, while in the case of pharmacotherapy, 
these figures appear to be 13, 37 and 26, respectively.
For the individuals who were unwilling to quit smoking, 
187 of the smokers did not receive a brief intervention 
(figure 2).
Table 2 Factors associated with nicotine dependence among regular smokers according to the multivariate logistic 
regression analysis (ORs with corresponding 95% CI)
Variables Low dependence Moderate dependence High dependence
Gender (reference: female)
  Male 0.39 (0.21 to 0.73) 0.77 (0.55 to 1.07) 1.89 (1.31 to 2.72)
Age group (reference: 18–34)
  35–64 0.65 (0.33 to 1.26) 0.93 (0.64 to 1.36) 1.25 (0.83 to 1.89)
  65+ 0.24 (0.05 to 1.22) 0.92 (0.48 to 1.75) 1.57 (0.79 to 3.12)
Education level (reference: primary or less)
  Vocational 1.11 (0.46 to 2.68) 1.74 (1.19 to 2.54) 0.54 (0.36 to 0.80)
  High school 3.37 (1.55 to 7.32) 1.62 (1.05 to 2.48) 0.36 (0.22 to 0.58)
  Tertiary 6.95 (2.65 to 18.27) 1.20 (0.60 to 2.38) 0.27 (0.11 to 0.68)
Tobacco-related diseases (reference: no 
disease)
  Cardiovascular 1.26 (0.50 to 3.19) 0.97 (0.59 to 1.60) 0.97 (0.56 to 1.66)
  COPD 0.86 (0.10 to 7.69) 1.40 (0.46 to 4.28) 0.72 (0.21 to 2.42)
COPD, Chronic obstructive pulmonary disease.
Table 3 Factors affecting smoking cessation service provision for regular smokers in primary healthcare by multivariate 
logistic regression analysis (ORs with corresponding 95% CI)
Variables Brief intervention Programmatic support Any cessation support
Gender (reference: female)
  Male 0.99 (0.66 to 1.47) 0.50 (0.28 to 0.91) 0.81 (0.56 to 1.15)
Age group (reference: 18–34)
  35–64 0.46 (0.29 to 0.70) 2.12 (1.01 to 4.46) 0.71 (0.48 to 1.06)
  65+ 0.41 (0.19 to 0.88) 1.46 (0.37 to 5.84) 0.54 (0.26 to 1.11)
Education level (reference: primary or less)
  Vocational 1.46 (0.93 to 2.31) 2.23 (1.03 to 4.84) 1.71 (1.13 to 2.59)
  High school 1.74 (1.05 to 2.89) 3.42 (1.54 to 7.60) 2.08 (1.31 to 3.31)
  Tertiary 0.50 (0.17 to 1.48) 2.47 (0.77 to 7.88) 1.00 (0.44 to 2.29)
Tobacco-related diseases (reference: no 
disease)
  Cardiovascular 6.58 (3.80 to 11.37) 0.30 (0.09 to 1.03) 3.91 (2.33 to 6.54)
  COPD 4.58 (1.36 to 15.46) 1.22 (0.14 to 10.42) 3.34 (1.04 to 10.68)
HSI (reference: moderate to high)
  Low 0.30 (0.12 to 0.75) 1.30 (0.53 to 3.23) 0.50 (0.24 to 1.01)
Intention to quit (reference: no)
  Yes 1.49 (1.00 to 2.22) 0.87 (0.48 to 1.56) 1.17 (0.82 to 1.67)
COPD, Chronic obstructive pulmonary disease; HSI, Heaviness of Smoking Index.
group.bmj.com on February 3, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
6 Sipos V, et al. BMJ Open 2018;8:e018932. doi:10.1136/bmjopen-2017-018932
Open Access 
dIsCussIOn
The knowledge of nicotine dependence and its determi-
nants is of key importance for the development of effi-
cient tobacco control strategies and proper application of 
SCS methods.11 Since in Hungary, no data have yet been 
published concerning the distribution of nicotine depen-
dence as well as care for adult smokers, our results can fill 
these gaps.
Main findings in an international context
In Hungary, 30% of tobacco users showed high nicotine 
dependence. A similar proportion of highly dependent 
smokers can be observed in Russia (30%) and Poland 
(28%), while Ukraine (26%) and Romania (25%) show 
a somewhat lower frequency.13 According to our study, a 
high dependence is more likely to occur among men but 
less likely among people with a high school and tertiary 
education level. Our observations were in agreement with 
findings from Central-Eastern European countries with 
socioeconomic structures similar to Hungarian ones, and 
from surveys which applied similar sampling and assess-
ment methods as we did our investigation. The proportion 
of high dependence among men compared with women 
was a bit higher than reported in Poland (OR=1.5), 
Romania (OR=1.5) and less than in Russia (OR=2.7), but 
neither of them was significant; in Romania, there was 
a greater likelihood of high dependence among people 
with low levels of education (OR=2.3) compared with 
those with a tertiary education level.13
SCS activities of Hungarian GPs (25% of tobacco 
users received brief intervention, 7% and 2% were given 
programmatic non-pharmacological and pharmacolog-
ical support) deviates profoundly from data published 
in international reports. The corresponding indicators 
for other countries are remarkably higher. According 
to a survey conducted in the USA, 50% of tobacco users 
were provided by counselling in PHC.15 In Ontario, the 
rate of smoking cessation counselling is 74%.16 While the 
brief intervention frequency exceeds 50% in the UK, this 
figure in the Netherlands is approximately 10%, and it 
is 22% in Australia and 27% in Italy.17–21 The proportion 
of programmatic non-pharmacological support is 14.1% 
in Australia and 27.8% in the UK.15 In Ontario, 25% of 
tobacco users received pharmacotherapy.16 According to 
a survey conducted in the UK, this proportion was 7%, 
but other surveys refer to a frequency over 40%.15 22
Altogether, considering the wide variability in published 
findings, the Hungarian PHC performance in SCS is weak, 
both in comparison with the evidence-based recommen-
dation and in comparison with the performance reported 
from other countries. The intensity of brief interven-
tions belongs to the weaker performances. The intensity 
of programmatic interventions is out of the published 
range. Pharmacological support for smoking cessation is 
practically missing from the practice of Hungarian GPs.
Based on our findings, during brief interventions, GPs 
place greater emphasis on patients suffering from chronic 
diseases, highly dependent patients and those who want 
to quit smoking. Bringing the focus on caring for tobacco 
users who are willing to quit as well as taking greater care 
of smokers suffering from chronic diseases are good 
Figure 2 Number of patients in a typical Hungarian general medical practice provided and not provided with smoking 
cessation support in primary healthcare by subgroups of regular smokers. HSI, Heaviness of Smoking Index.
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aspects of the Hungarian PHC practice. In this respect, 
the Hungarian PHC follows international practices.22 23
However, for successful cessation, GPs should focus 
more on the care of patients with low and moderate 
dependence. Although highly dependent patients are 
more likely to seek for SCS, they are less successful in 
maintaining abstinence compared with low-dependence 
patients.14 24
required extra workload to meet recommendations
The regular assessment of smoking behaviour of clients, 
which covers the assessment of nicotine dependence and 
willingness to give up smoking, which is completed with 
brief intervention for the regular smokers, takes substan-
tial working time of the team members of PHC. Initiation 
of programmatic smoking cessation increases further the 
needed working time. This amount of work seems to be 
not expectable from a traditional PHC team of one GP 
and one nurse providing care for approximately 1600 
adult clients, as it is typical in Hungary.
On the other hand, the most activities of SCS do not 
require medical expertise. Trained health professionals 
(eg, nurses, public health experts) can provide those. 
Organised collaboration of traditional PHC team with 
non-medical health professionals could ensure the base 
for the required development. The SCS with many other 
missing preventive services of the PHC belongs to the 
package of interventions with evidence base, which could 
improve significantly the health status of provided adults, 
if the necessary structural development could be imple-
mented somehow.25–27
strengths and limitations
According to the EHIS data from 2014, 26.4% of the 
adult population smokes on a regular basis (95% CI 
25.3% to 27.6%). The frequency of smoking among men 
was 32.0% (95% CI 30.2% to 33.8%), while the frequency 
among women was 21.7% (95% CI 20.2% to 23.1%). As 
this frequency does not differ significantly from our expe-
rience, this survey provides reliable and demographically 
representative data on the care of smokers.
However, our study was carried out with GPs who 
undertook voluntary participation in the GPMSSP. It 
can be supposed that GPs less conscientious in SCS are 
over-represented in the study. Due to this selection bias, 
the quality of care provided by GPMSSP members may 
be better than the average in Hungary. Therefore, our 
results overestimate the actual quality. The care for adult 
smokers in Hungary is lagging behind our study results. 
Consequently, the quality of care by Hungarian GPs 
for regular smokers is somewhat worse than we could 
determine, and the gap among reference countries and 
Hungary is wider than we actually observed.
Our study did not investigate in detail the GMP and 
patient-related factors which influence the effective-
ness of SCS. In addition, having no data on the typical 
working time for SCS interventions, the number of 
missing services could not be transformed into number of 
missing working hours. Therefore, further investigations 
are needed to explore the determinants of SCS effective-
ness, and to estimate the necessary extra working time to 
make up for missing services.
COnClusIOns
The proportion of highly dependent smokers in Hungary 
shows a pattern similar to Eastern European observa-
tions. Based on the process indicators for care, it seems 
that within the framework of PHC, tobacco users fail to 
receive the proper support necessary to quit smoking as 
specified in the guidelines. Healthcare services provided 
by GPs are mainly influenced by the age, gender, educa-
tion, existing chronic diseases and the level of nicotine 
dependence of smokers. According to our estimations, 
the provision of guideline-adherent SCS could increase 
the workload of GPs considerably. Therefore, supportive 
capacities are needed to enable the PHC for providing 
SCS as it is recommended by evidence-based guidelines.
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